Vysioneer LLC
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.
Founded Year
2018
Unified Business No.
50892131
Status
Active
Number of Employees
0
Total Paid-in
Capital
52,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in the fight against cancer.
Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.
Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.
